Register Login

Nurix Therapeutics Inc (NRIX)

(75% Positive) NURIX THERAPEUTICS, INC. (NRIX) Announces Enrollment Update for medicines Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Full text
Register to leave comments
  • News bot Oct. 22, 2025, 1:06 p.m.

    📋 NURIX THERAPEUTICS, INC. (NRIX) - Clinical Trial Update

    Filing Date: 2025-10-22

    Accepted: 2025-10-22 09:04:11

    Event Type: Clinical Trial Update

    Event Details:

    Nurix Therapeutics Inc (NRIX) Announces Clinical Trial Update Nurix Therapeutics Inc (NRIX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: medicines
    • Clinical Stage: Phase 2 study, Phase 2
    • Collaboration: Healthcare
    • Updated Timeline: October 22, 2025

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Nurix Therapeutics Inc
    • CIK: 0001549595
    • Ticker Symbol: NRIX
    • Period End Date: 2025-10-22
    • Document Type: 8-K

Search

News categories